过去一年中添加的文章,按日期排序

[PDF][PDF] The role of chemoradiotherapy and immunotherapy in stage III NSCLC

Z Orosz, Á Kovács - Pathology and Oncology Research, 2024 - por-journal.com
114 天前 - … However, in clinical practice, we can also identify stage lung … non-small cell lung
cancer, especially of adenocarcinomas, it is … Changes in F-18 fluorodeoxyglucose uptake occur …

[HTML][HTML] Machine learning for differentiating lung squamous cell cancer from adenocarcinoma using Clinical-Metabolic characteristics and 18F-FDG PET/CT radiomics

Y Zhang, H Liu, C Chang, Y Yin, R Wang - Plos one, 2024 - journals.plos.org
118 天前 - … ) and adenocarcinoma (ADC) subtypes of non-small cell lungPET/CT-based
radiomics model. It aims to distinguish between the histological subtypes of lung adenocarcinoma

Phenotypic Oncology PET

AI Casebook, CYO Wong, D Wu - Springer
119 天前 - … has a lower uptake in F-18 FDG PET than that of a high-grade … In lung cancer,
these PET phenotypes are more useful … than that of the well-differentiated adenocarcinoma. In …

[HTML][HTML] COMPARISON OF 18F-FDG AND 18F-PSMA PET/CT IN PATIENTS WITH NON-SMALL CELL LUNG CANCER

NAA Silveira, MWP Júnior, HN Ide… - … , Transfusion and Cell …, 2024 - Elsevier
121 天前 - lung cancer (including two adenocarcinomas, … -FDG PET/CT scans were performed
60 minutes after intravenous administration of 0.1 mCi/kg of 18F-FDG, while 18F-PSMA PET/…

213 Selpercatinib in RET Fusion Lung Adenocarcinoma

R Bulusu, S Paul, N Brown, G Punnen, AK Geetha… - Lung Cancer, 2024 - Elsevier
121 天前 - … RET fusions are observed in 1–2% of lung adenocarcinomas (LAC) and result in
ligand independent constitutive activation of RET pathway. Selpercatinib is a selective RET …

Clinical Prognostic and Predictive Biomarkers

Y Huang, Y Yuan, P Chen - 2024 - mdpi.com
124 天前 - In this Special Issue, we finally included 20 papers, focused on multiple clinical
diseases, including cancers, infectious diseases (COVID-19, pancreatitis, etc.), autoimmune …

[HTML][HTML] Preoperative evaluation of mediastinal lymph nodes in non-small cell lung cancer using [68Ga]FAPI-46 PET/CT: a prospective pilot study

Y Kang, KJ Na, J Park, N Kwak, YS Lee, H Choi… - European Journal of …, 2024 - Springer
146 天前 - … A 62-year-old female patient diagnosed with lung adenocarcinoma. There was no
… a higher number of metastatic nodes in advanced lung cancer than [ 18 F]FDG PET/CT [24]. …

A solitary rod‐shaped intertrabecular metastasis in the femur

M Yokoyama, T Inui, T Namiki, H Ishikawa… - Respirology Case …, 2024 - ncbi.nlm.nih.gov
147 天前 - … ITM of lung adenocarcinoma in the femur. … adenocarcinoma. Positron emission
tomography/computed tomography (PET/CT) showed uptake of 18 F‐fluorodeoxyglucose (…

[HTML][HTML] 49P Perioperative circulating tumor DNA redefines induced oligometastatic non-small cell lung cancer at the molecular level

R Fu, YY Xiong, M Cai, F Li, R Chen, YL Wu… - ESMO Open, 2024 - esmoopen.com
152 天前 - … In this prospective, observational study, we enrolled patients with oligometastatic
NSCLC identified through 18 F-FDG-PET/CT following systemic therapy. Patients underwent …

Prediction of epidermal growth factor receptor mutation status by textural features in stage IV lung adenocarcinoma

C Wang, R Zhang, X Sun, L Xing - memo-Magazine of European Medical …, 2024 - Springer
153 天前 - … cytology results of lung adenocarcinoma; (2) 18F-PET/CT … lung adenocarcinoma
who underwent pretreatment 18F-FDG PET scans were analyzed, and all of them were lung